SBIR/STTR Research Award
Retroviral Vectors for Safe and Efficacious Gene Therapy
Award amount
$148,499Program and phase
SBIR · Phase IAward year
2004Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Neumedicines Inc.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- PHS2004-2
- Topic code
- Not reported
Research abstract
DESCRIPTION (provided by applicant): The goal of this proposal is to engineer safer more efficacious vectors for use in human gene therapy. The development of safer and more efficient retroviral vectors has significant commercial potential in that the
Technology keywords
Not reported